FindTrial
Sign In

Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up

Follow Up by Multimodal MRI of a Cohort of Patients With Early Remitting Multiple Sclerosis (REPROMMS Study).

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00289159
Enrollment
Unknown
Registered
2006-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2006-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

aged 18-50, remitting evolution, less than two years of evolution, MS patients

Brief summary

To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.

Interventions

None listed

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
Groupe Hospitalier Pitie-Salpetriere
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* MS patients according to Poser's criteria * Remitting evolution (less than two years of evolution) * Aged 18-50 * Immunomodulatory treatment indicated

Exclusion criteria

* Unable to perform MRI

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026